Impact BioMedical Inc.
Impact BioMedical Inc. (IBO) Revenue
Annual & quarterly revenue history · segment & region breakdown
IBO · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsImpact BioMedical Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Impact BioMedical Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Impact BioMedical Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Impact BioMedical Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
IBO revenue · 4 questionsIBO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Impact BioMedical Inc. SEC filings · GAAP · Impact BioMedical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026